Author

E. Yu. Vasilyeva

Observed names: E. Vasilieva, Elena J. Vasilieva

Institutions: Russian Society of Cardiology, City Clinical Hospital

Observed institutions: Russian University of Medicine, Pirogov Russian National Research Medical University, Ministry of Health of the Russian Federation, Russian Society of Cardiology, Scientific Research Institute of Healthcare Organization and Medical Management, City Clinical Hospital, Moscow Multidisciplinary Clinical Center "Kommunarka"

ORCID: 0000-0002-6310-7636

Observed ORCID: 0000-0002-6310-7636

OpenAlex ID: A5113077624

2025 Clinical practice guidelines for Atrial fibrillation and flutter

2026 · E. Z. Golukhova, S. P. Golitsyn, et al. · Russian Journal of Cardiology · 44

Novel coronavirus infection COVID-19: extrapulmonary manifestations

2020 · I. V. Maev, A. V. Shpektor, et al. · Terapevticheskii arkhiv · 37

Non-immunogenic staphylokinase — a thrombolytic agent in the treatment of massive pulmonary embolism: results of the FORPE clinical trial

2024 · A. I. Kirienko, S. G. Leontyev, et al. · Russian Journal of Cardiology · 9

Effectiveness of inclisiran lipid-lowering therapy in patients with atherosclerotic cardiovascular disease in Moscow healthcare

2024 · A. I. Sapina, Yu. Yu. Varlamova, et al. · Russian Journal of Cardiology · 5

Lipid deposition as a common feature of pneumonias of different etiologies

2026 · Daria M. Potashnikova, Anna V. Tvorogova, et al. · The American Journal of Medicine · 4

Observational study of inclisiran effectiveness in Moscow healthcare

2023 · A. I. Sapina, Yu. Yu. Varlamova, et al. · Russian Journal of Cardiology · 4

Use of antiplatelet agents in patients after myocardial infarction followed up in Moscow outpatient clinics. Results of a non-interventional prospective study

2024 · A. I. Sapina, A. Yu. Lebedeva, et al. · Russian Journal of Cardiology · 1

Mechanical circulatory support in refractory cardiogenic shock: retrospective register study

2022 · Polina P. Savvinova, Vladimir N. Manchurov, et al. · Terapevticheskii arkhiv · 1

Evaluation of lipoprotein(a) — a novel cardiovascular risk factor in patients with atherosclerotic cardiovascular diseases receiving PCSK9-targeted therapy in Russian real-world practice

2024 · A. I. Sapina, Yu. Yu. Varlamova, et al. · Russian Journal of Cardiology

2015 · V. Ionin, O. Listopad, et al. · Journal of Hypertension

Works count: 10

Citation count: 105

H-index: 4

I10-index: 2